Measurement of AKI biomarkers in the ICU: still striving for appropriate clinical indications

Intensive Care Medicine

Volumn 41, Issue 3, 2015, Pages 541-543

  Prowle, John R ^a,b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; IGFBP 7 PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; CREATININE BLOOD LEVEL; EARLY DIAGNOSIS; EDITORIAL; HUMAN; INTENSIVE CARE UNIT; OLIGURIA; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); URINE VOLUME; BLOOD; FEMALE; KIDNEY FAILURE; MALE; URINE;

FEMALE; HUMANS; MALE; OLIGURIA; RENAL INSUFFICIENCY;

EID: 84925483262     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-3662-z     Document Type: Editorial

References (15)

1. Kidney Disease Improving Global Outcomes (2012) Clinical practice guideline for acute kidney injury. Section 2: AKI definition. Kidney Inter Suppl 2:19–36
2. Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W (2013) Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 28:254–273
3. Devarajan P (2010) Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 4:265–280
4. Glassford NJ, Schneider AG, Xu S, Eastwood GM, Young H, Peck L, Venge P, Bellomo R (2013) The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury. Intensive Care Med 39:1714–1724
5. Hjortrup PB, Haase N, Treschow F, Moller MH, Perner A (2015) Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis. Acta Anaesthesiol Scand 59:25–34
6. Legrand M, Jacquemod A, Gayat E, Collet C, Giraudeaux V, Launay JM, Payen D (2015) Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria. Intensive Care Med 41:68–76. doi:10.1007/s00134-014-3566-3
7. Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, Fitzgerald R, Gong MN, Graham DD, Gunnerson K, Heung M, Jortani S, Kleerup E, Koyner JL, Krell K, Letourneau J, Lissauer M, Miner J, Nguyen HB, Ortega LM, Self WH, Sellman R, Shi J, Straseski J, Szalados JE, Wilber ST, Walker MG, Wilson J, Wunderink R, Zimmerman J, Kellum JA (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189:932–939
8. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmele T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent JL, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25
9. Ostermann M, Joannidis M (2014) Biomarkers for AKI improve clinical practice: no. Intensive Care Med (Epub Nov 12)
10. de Geus HR, Fortrie G, Betjes MG, van Schaik RH, Groeneveld AB (2013) Time of injury affects urinary biomarker predictive values for acute kidney injury in critically ill, non-septic patients. BMC Nephrol 14:273
11. McCullough PA, Shaw AD, Haase M, Bouchard J, Waikar SS, Siew ED, Murray PT, Mehta RL, Ronco C (2013) Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 182:13–29
12. Pickering JW, Endre ZH (2012) New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol 7:1355–1364
13. Pepe MS (2011) Problems with risk reclassification methods for evaluating prediction models. Am J Epidemiol 173:1327–1335
14. Prowle JR, Liu YL, Licari E, Bagshaw SM, Egi M, Haase M, Haase-Fielitz A, Kellum JA, Cruz D, Ronco C, Tsutsui K, Uchino S, Bellomo R (2011) Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care 15:R172
15. Waikar SS, Betensky RA, Emerson SC, Bonventre JV (2012) Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol 23:13–21